Three peptides studied for sleep depth, circadian timing, and calming the nervous system
Deep sleep depends on the brain's calming signals, a well-timed body clock, and stress hormones that fall at night. The research here centers on DSIP, which was studied directly for sleep depth in people; Epithalon, studied for restoring nighttime melatonin and circadian rhythm; and Selank, studied for calming through the brain's main inhibitory system. Human data exist for all three, but with important limits.
1The biology of this goal
Sleep is not a single "off" switch. It moves through stages, and the deepest stage — called slow-wave or delta sleep — is when the body feels most restored. Getting into that deep sleep depends on several things working together: a calming chemical system in the brain (called GABA) that quiets nerve activity, a body clock that releases the sleep hormone melatonin at night, and stress hormones like cortisol dropping as bedtime approaches. When these signals are out of sync — for example from shift work or aging — sleep becomes lighter and less refreshing. The compounds here are studied for nudging these systems back toward a normal nighttime pattern rather than knocking a person out.
Human trials report that DSIP increased total sleep time and improved next-night sleep efficiency, and that its levels correlate with deep sleep stages.
DSIP, short for delta sleep-inducing peptide, is a tiny nine-building-block peptide first found in the blood of sleeping rabbits in the 1970s. It is named for increasing deep, slow-wave sleep, and it appears to support natural sleep rather than sedate like a sleeping pill. Even after decades of study, no specific receptor or gene for it has been found, so exactly how it works is still unsettled.
In a double-blind cross-over study in six normal volunteers, DSIP given as slow intravenous infusion increased sleep by 59% (median total sleep time) within a 130-minute window after treatment compared with placebo.1
Subjects immediately reported a feeling of sleep pressure after DSIP, yet EEG and behavioral analysis showed no sedation in the classic pharmacologic way.1
DSIP produced delayed effects on the following night's sleep, including shorter sleep onset, reduced stage 1 sleep, and better sleep efficiency.1
DSIP has been reported to increase sleep in people with insomnia, and cerebrospinal fluid DSIP-like immunoreactivity correlated with stage 3 sleep (p = 0.05) and with stage 3 plus delta sleep during the first NREM period, while correlating negatively with lighter stage 2 sleep.2
Reviews note DSIP was isolated from rabbit cerebral venous blood in 1977 but that the link to sleep has never been fully characterized, in part because the DSIP gene, protein, and possible receptor have never been isolated.3
What this doesn't establish
The controlled human sleep trial involved only six healthy volunteers and used morning intravenous infusion, and the reviews note the DSIP-as-sleep-factor hypothesis remains poorly documented because no receptor or gene has been isolated; effects in healthy sleepers were described as modest.
Human trial data report that Epithalon normalized circadian clock-gene expression and increased a melatonin metabolite in people with reduced pineal function, with animal studies supporting effects on melatonin and cortisol rhythm.
Epithalon is a synthetic four-building-block peptide (Ala-Glu-Asp-Gly) modeled on a natural pineal gland extract. Its relevance to sleep is through the body clock: researchers report it helps restore normal nighttime melatonin production and the rhythm of stress and sleep hormones. This matters for people whose melatonin signal has weakened with age or shift work.
In middle-aged people with reduced melatonin-producing pineal function, AEDG peptide normalized hyper-expression of the Clock and Csnk1e genes in leukocytes (by 1.9–2.1 times) and increased hypo-expressed Cry2 in lymphocytes (by 2 times), which researchers attribute to restoring the pineal's melatonin-producing function through circadian gene regulation.4
Preclinical reviews describe epithalamin, the extract Epithalon is derived from, stimulating melatonin production in old rats and in elderly adults with pineal dysfunction, while noting Epithalon itself failed to stimulate melatonin in rats but reportedly raised it in older primates.5
Animal studies report that epithalamin increases pineal melatonin production in rats and that Epitalon restores the circadian rhythms of both melatonin and cortisol in old rhesus monkeys.6
What this doesn't establish
None of the supplied evidence measured sleep depth, sleep stages, or subjective sleep quality directly; the human findings concern gene expression and a melatonin metabolite, and much of the supporting melatonin and cortisol data comes from rats and monkeys.
DSIP and Epithalon act on the same downstream target — normal nighttime melatonin and circadian rhythm — but from different starting points: DSIP influences pineal melatonin and delta sleep directly, while Epithalon is reported to restore the pineal melatonin axis and circadian clock genes. In principle they could reinforce circadian normalization, though this combination has not been tested directly in the supplied evidence. DSIP and Selank both touch the brain's GABA calming system and enkephalin signaling, making them a plausible calming or sleep-support pairing, but their overlapping sedative-leaning effects would warrant monitoring if combined. There is no documented interaction between Epithalon and Selank in this data, which reflects absence of study rather than a demonstration of safety.
DSIP + Selank
Worth caution — see why below
Both peptides calm the nervous system through overlapping routes: DSIP enhances GABA-A currents and releases enkephalins, while Selank is an anxiolytic that positively modulates GABA-A signaling and boosts enkephalins by inhibiting enkephalinase (neprilysin). Their shared GABA and enkephalin actions make this a plausible anxiolytic/sleep-support pairing, though the combined sedative/calming effect should be monitored.
DSIP + Epithalon
May be complementary
Both peptides converge on restoring normal melatonin secretion and circadian rhythm, but by different upstream mechanisms: DSIP influences pineal melatonin synthesis and delta sleep, while Epithalon reportedly upregulates the pineal melatonin (AANAT) axis and circadian clock genes. Used together they could reinforce circadian normalization and sleep timing.
1 other pairing has no documented interaction in our data — that is not a safety clearance.
Epithalon + Selank
4Related but not studied for this goal
These share some of this goal's biology and are not off-target — but their research is elsewhere: on the skin, or on another condition. Listed so you know we saw them.
Cortexin shares gaba signalling with this goal, but only 3 of its 150 research claims mention sleep deeper and wake up restored; it has not been studied for it.
MK-677 shares sleep architecture with this goal, but only 3 of its 155 research claims mention sleep deeper and wake up restored; it has not been studied for it.
Sermorelin shares sleep architecture with this goal, but only 3 of its 148 research claims mention sleep deeper and wake up restored; it has not been studied for it.
Selank shares gaba signalling with this goal, but only 5 of its 138 research claims mention sleep deeper and wake up restored; it has not been studied for it.
This brief reports what published research says about these compounds. It is information, not medical advice, and not a recommendation to use anything described here. Evidence quality varies by compound and is labelled throughout. Talk to a qualified clinician before acting on any of it.
See something wrong or out of date on this page? Report it.